| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |